Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Psyence Group Inc (PSYG.CN)

Psyence Group Inc (PSYG.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,877
  • Shares Outstanding, K 15,638
  • Annual Sales, $ 0 K
  • Annual Income, $ -30 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 3.65
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.68
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -1.06
  • Most Recent Earnings $-0.92 on 08/29/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING:

    SIC-2834 Pharmaceutical Preparations

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1100 +9.09%
on 11/19/25
0.1550 -22.58%
on 10/24/25
unch (unch)
since 10/17/25
3-Month
0.1100 +9.09%
on 11/19/25
0.1650 -27.27%
on 09/26/25
-0.0350 (-22.58%)
since 08/21/25
52-Week
0.0150 +700.00%
on 04/24/25
0.3750 -68.00%
on 11/25/24
-0.1800 (-60.00%)
since 11/21/24

Most Recent Stories

More News
Upcoming Meeting Dates - December 8, 2025

Toronto, Ontario--(Newsfile Corp. - December 8, 2025) - The following is a list of Upcoming Meeting Dates for Reporting Issuers in Canada. The data is supplied by Issuing Companies through the service...

BBB.VN : 0.070 (unch)
TUF.VN : 0.210 (+7.69%)
SPOD.CN : 0.0200 (unch)
JTC.VN : 0.950 (unch)
SPC.VN : 0.080 (+6.67%)
TBRD.VN : 1.660 (+5.06%)
TM.VN : 0.245 (unch)
VIZ.VN : 0.065 (unch)
VRTX.CN : 0.5100 (unch)
WBGD.CN : 0.0950 (unch)
TRBR.VN : 1.580 (-0.32%)
VVC.VN : 0.015 (unch)
Psyence Group Inc. Enters into Amalgamation Agreement with Goldcoast Resource Corp.

TORONTO, ON / ACCESS Newswire / November 24, 2025 / Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company") is pleased to announce that, further to its news release dated August 22, 2025, it has entered...

PSYG.CN : 0.1200 (unch)
Psyence Group Inc. Announces RSU Grants

TORONTO, ON, ON / ACCESS Newswire / October 17, 2025 / Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company"), announces that it granted an aggregate of 721,448 restricted share units (each an "RSU")...

PSYG.CN : 0.1200 (unch)
Psyence Group Inc. Enters Into a Letter of Intent to Acquire Goldcoast Resource Corp.

TORONTO, ON / ACCESS Newswire / August 22, 2025 / Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company"), announces that it has entered into a letter of intent (the "LOI") to acquire all of the issued...

PSYG.CN : 0.1200 (unch)
Psyence Group Inc. Closes Second Tranche of Non‑Brokered Private Placement for Remaining Proceeds

TORONTO, ON / ACCESS Newswire / July 7, 2025 / Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company"), is pleased to announce that it has successfully closed the second tranche ("Tranche 2") of its...

PSYG.CN : 0.1200 (unch)
FILAMENT HEALTH AND PSYENCE ANNOUNCE WORLDWIDE LICENSING AGREEMENT OF PSILOCYBIN CAPSULE FOR PALLIATIVE CARE

/CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament"), a clinical-stage natural psychedelic drug development company, and Psyence...

FLHLF : 0.0001 (unch)
PSYG.CN : 0.1200 (unch)
PSYGF : 0.1270 (+11.21%)
The Power Play by The Market Herald Releases New Interviews with Avrupa Minerals, good natured Products, Hank Payments, Psyence Group, and Empower Clinics

VANCOUVER, BC / ACCESSWIRE / June 2, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Avrupa Minerals, good natured Products, Hank Payments, Psyence Group, and...

GDNP.VN : 0.015 (unch)
PSYG.CN : 0.1200 (unch)
AVU.VN : 0.055 (+10.00%)
HANK.VN : 0.045 (+28.57%)
CBDT.CN : 0.050 (unch)
Psyence Group Corporate Update

Highlights: Partnership with CRO Clerkenwell Health to design and deliver Psyence’s UK clinical trial progressing; exclusive licensing agreement with...

PSYG.CN : 0.1200 (unch)
PSYGF : 0.1270 (+11.21%)
Psyence Taps Another Pharma Exec to Drive its Clinical Program

TORONTO, May 31, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology...

PSYG.CN : 0.1200 (unch)
PSYGF : 0.1270 (+11.21%)
Market Movers. Today’s Top Stock Picks For New & Trending Opportunities

Market Movers. Today's Top Stock Picks For New & Trending Opportunities

VEJI.CN : 0.0050 (-50.00%)
EWGFF : 0.0200 (+3,233.33%)
CRDL.TO : 1.50 (+7.91%)
VEJIF : 0.3420 (-30.90%)
NFTX.NE : 0.3350 (-1.47%)
CRDL : 1.0800 (+8.00%)
BAU.VN : 0.170 (+6.25%)
EWG.CN : 0.1700 (unch)
WINS.VN : 0.090 (-14.29%)
HELOF : 0.0911 (-8.90%)
PSYG.CN : 0.1200 (unch)
LIT.VN : 0.145 (+7.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Psyence Group Inc is a life science biotechnology company focused on the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma in the context of palliative care and support of mental wellness. It is involved in cultivating and exporting psilocybin...

See More

Key Turning Points

3rd Resistance Point 0.1200
2nd Resistance Point 0.1200
1st Resistance Point 0.1200
Last Price 0.1200
1st Support Level 0.1200
2nd Support Level 0.1200
3rd Support Level 0.1200

See More

52-Week High 0.3750
Fibonacci 61.8% 0.2375
Fibonacci 50% 0.1950
Fibonacci 38.2% 0.1525
Last Price 0.1200
52-Week Low 0.0150

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar